Literature DB >> 1747458

Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia.

K Takai1, M Sanada.   

Abstract

We report a case of hypereosinophilic syndrome (HES) which later evolved into acute lymphoblastic leukemia (ALL). A 37-year-old man showed typical clinical manifestations of HES: pulmonary infiltrates, erythematous skin rash, deep vein thrombosis, endomyocardial fibrosis, and diffuse central nervous system dysfunctions. Although he was treated with prednisolone and hydroxyurea, marked eosinophilia persisted and lymphoblasts gradually increased in the bone marrow. He died of severe disseminated fungal infection after anti-leukemic therapy. Autopsy revealed marked fibrous thickening of the endocardium, bilateral common iliac vein thrombosis, and chronic hepatitis with fibrosis. Neither eosinophilic nor leukemic cell infiltration was seen in any tissue at autopsy. Including this case, 24 patients with ALL and hypereosinophilia have been reported in English-language literature. We discuss the relationship between eosinophilia and ALL, and the mechanisms, particularly the role of eosinophil cationic protein (ECP), in causing various organ system dysfunctions in HES.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1747458

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  5 in total

1.  Acute lymphoblastic leukemia with eosinophilia lacking peripheral blood leukemic cell: a rare entity.

Authors:  Hiroto Kaneko; Kazuho Shimura; Mihoko Yoshida; Yasuo Ohkawara; Muneo Ohshiro; Yasuhiko Tsutsumi; Toshiki Iwai; Shigeo Horiike; Shohei Yokota; Masafumi Taniwaki
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

2.  Eosinophilic myelodysplasia transforming to acute lymphoblastic leukaemia.

Authors:  G A Follows; R G Owen; A J Ashcroft; L A Parapia
Journal:  J Clin Pathol       Date:  1999-05       Impact factor: 3.411

3.  Thromboembolism in a patient with transient eosinophilia.

Authors:  H Y Mukai; H Ninomiya; S Mitsuhashi; Y Hasegawa; T Nagasawa; T Abe
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673

4.  Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma.

Authors:  Tilman Todenhöfer; Stefan Wirths; Claus Hann von Weyhern; Stefan Heckl; Marius Horger; Joerg Hennenlotter; Arnulf Stenzl; Lothar Kanz; Christian Schwentner
Journal:  BMC Urol       Date:  2012-03-21       Impact factor: 2.264

5.  ICON: Eosinophil Disorders.

Authors:  Peter Valent; Amy D Klion; Lanny J Rosenwasser; Michel Arock; Bruce S Bochner; Joseph H Butterfield; Jason Gotlib; Torsten Haferlach; Andrzej Hellmann; Hans-Peter Horny; Kristin M Leiferman; Georgia Metzgeroth; Kenji Matsumoto; Andreas Reiter; Florence Roufosse; Marc E Rothenberg; Hans-Uwe Simon; Karl Sotlar; Peter Vandenberghe; Peter F Weller; Gerald J Gleich
Journal:  World Allergy Organ J       Date:  2012-12       Impact factor: 4.084

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.